Managed Care Cast

On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening. Farhood Farjah, MD, MPH, FACS, is thoracic surgeon at the University of Washington, and a senior investigator of the study, “Factors Associated With Lung Cancer Risk Factor Documentation.”

In part 2 of this 2-part podcast, a panel of experts discusses challenges with biosimilar uptake, interchangeability studies, patient and provider education.

Florida Cancer Specialists & Research Institute's (FCS') Nathan Walcker, chief executive office at FCS, discusses some key strategic practices and initiatives in providing high quality community-based oncology care he has implemented at FCS.

In part 1 of this 2-part podcast, a panel of experts discusses the clinical manifestations of inflammatory diseases and the potential for biosimilars to treat these diseases.

At this year’s American Society for Preventive Cardiology’s Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award—having received the honor for her extraordinary contributions to the field of preventive cardiology. She stopped by to talk with AJMC while in Arlington, Texas, and our conversation covered everything from just what AFib is to risk factors and prevention strategies to connections between AFib and noncardiovascular health conditions to long-term data on stroke.

Jeff Patton, MD, CEO and board member of OneOncology and executive chairman of Tennessee Oncology, joins hosts Emeline Aviki, MB, MBA, of NYU Langone Perlmutter Cancer Center, and Stephen Schleicher, MD, MBA, ofTennessee Oncology, for our third episode. Patton, also chairman of the Community Oncology Alliance and a board-certified hematologist and oncologist, highlights of the origins of OneOncology that it was created to protect community oncology, to give other states and communities the opportunity to stay independent in light of large hospital systems, if they wanted to. He also discusses the importance of community clinical trial accrual and of keeping oncological services within the community and not handing them over to large hospital systems, therby driving up the cost of care.

On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy. Shelley Jazowski, PhD, MPH, is a postdoctoral fellow at Vanderbilt University School of Medicine and lead researcher on “Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use." The authors compared the initiation of and adherence to orally administered antimyeloma therapy between enrollees receiving and not receiving the Medicare Part D low-income subsidy, and examined the association between these subsidies and racial and ethnic barriers to the use of these drugs.

On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the June 2023 issue of The American Journal of Managed Care® about how employers and their employees are utilizing direct-to-consumer (DTC) telehealth to reduce the cost of care. Krisda Chaiyachati, MD, MPH, is a general internist, primary care physician, and adjunct assistant professor of medicine at the University of Pennsylvania Health System, and the lead author of the study, “Economics of a Health System’s Direct-to-Consumer Telemedicine for Its Employees."

On this episode of Managed Care Cast, Kathy Leyden, vice president of community engagement at Capital District Physicians' Health Plan (CDPHP), discusses key initiatives and areas of focus to address hunger and food insecurity issues across Upstate New York.

On this episode of Oncology Onward, Dr. Debra Patt, executive vice president of policy and strategic initiatives and director of public policy at Texas Oncology joins cohosts Dr Emeline Aviki and Dr Stephen Schleicher for a jam-packed discussion that touches on topics that have never been more timely in the oncology space: the economics behind the current drug shortage, the relationship between pharmacy benefits managers and 340B discounts, and the Inflation Reduction Act.

On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the July 2023 issue of The American Journal of Managed Care® on whether social determinants of health is a predictor for identifying high-cost utilizers among those with commercial health insurance.

On this episode of Managed Care Cast, we’re talking with 2 individuals who were essential in the creation and implementation of the Health Access Initiative for Recovery (Our HAIR), launched by Community Care Behavioral Health Organization of Pittsburgh, PA.

On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.

In part 2 of this 2-part series on health equity in the treatment of psoriasis, Ryan Haumschild, PharmD, and Bryan Buckley, DrPH, discuss how providers can address disparities in psoriasis care, specifically with race, cultural, and ethnic backgrounds in mind.

On this episode of Managed Care Cast, we speak with Bruce W. Sherman, MD, of Case Western Reserve University School of Medicine, about a recent study on wage-level disparities effecting the utilization of mental health resources, for which he was lead investigator; the study articles appear in the April issue of The American Journal of Managed Care®.

On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.

Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration, sat for a conversation with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, that covered the cancer footprint of the VHA, from work within the newly reinvigorated Cancer Moonshot program and screening for vulnerable communities to the Million Veterans Program, the largest genomic database of its kind in the country and of Black Americans, including information on more than 150,000 Black veterans.

National Public Health Week is observed across the United States each year during the first full week of April, and this year will run from April 3-9. Originally conceived and organized by the American Public Health Association, and now in existence for more than 25 years, the theme this year is, “Centering and Celebrating Cultures in Health.” For National Public Health Week this year, we sat down with Kristen Krause, PhD, MPH, instructor in the Department of Urban-Global Public Health and deputy director, Center for Health, Identity, Behavior and Prevention Studies, Rutgers School of Public Health. Our conversation covered not only her current areas of research focus, but the importance of health equity among traditionally marginalized communities, how the early days of the HIV/AIDS epidemic shaped much of the worldview on public health, the influence of culture on many a health outcome, and lessons learned from past public health emergencies.

In part 1 of this 2-part series on health equity in the treatment of psoriasis, Ryan Haumschild, PharmD, and Bryan Buckley, DrPH, discuss how providers can address disparities in care, specifically with race, cultural, and ethnic backgrounds in mind.

On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.